Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue

Gian Luca Erre MD, PhD, Arduino Aleksander Mangoni MD

Article Type

Editorial

Published

This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs.

Read more

Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases

Valeria Nucera MD, Elisabetta Gerratana MD, Manuela Giallanza MD, Laura La Corte MD, Donatella Sangari MD, Fabiola Atzeni MD, PhD

Article Type

Review

Published

This review focuses on cyclophosphamide due to its crucial role in the treatment of systemic sclerosis-related interstitial lung disease, particularly in the case of patients with progressive Interstitial lung diseases.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.